PRAX
Praxis Precision Medicines, Inc.Company Information
- Company Name
- Praxis Precision Medicines, Inc.
- CIK
- CIK0001689548
- Category
- Large accelerated filer
- Ticker: Exchange
- PRAX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PRAX
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-10-05
- Last sale
- 2026-06-24
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 364,240
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 32,730,412
- Shares outstanding
- 29,131,375
- Ownership
- 112.35%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -6.86%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 475 | 536 | 357 | 150 | 157 | 166 | 215 | 169 | 145 | 152 | 81 | 101 | ||||||
| Available For Sale Securities Debt Securities | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | 118 | 144 | 162 | 177 | 188 | 207 | 55 | 0 | - | ||||||
| Marketable Securities Current | 284 | 251 | 242 | - | - | - | 177 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 13 | 11 | 12 | 7 | 5 | 6 | 12 | 3 | 5 | 4 | 4 | 2 | ||||||
| Assets Current | 772 | 798 | 611 | 274 | 307 | 334 | 404 | 360 | 357 | 212 | 85 | 103 | ||||||
| Marketable Securities Noncurrent | 615 | 661 | 327 | - | - | - | 77 | - | - | - | - | - | ||||||
| Available For Sale Securities Debt Securities Noncurrent | - | 911 | 569 | 122 | 145 | 144 | 254 | 54 | 82 | 36 | 0 | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1,390 | 1,460 | 938 | 396 | 453 | 479 | 483 | 416 | 441 | 250 | 88 | 107 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 23 | 31 | 25 | 31 | 29 | 23 | 13 | 15 | 8 | 9 | 6 | 7 | ||||||
| Accrued Liabilities Current | 25 | 18 | 35 | 22 | 19 | 16 | 24 | 15 | 10 | 7 | 7 | 7 | ||||||
| Operating Lease Liability Current | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 49 | 50 | 60 | 53 | 49 | 40 | 38 | 33 | 21 | 19 | 16 | 17 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 | 2 | ||||||
| Liabilities | 49 | 50 | 60 | 53 | 49 | 40 | 38 | 34 | 22 | 21 | 18 | 20 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 2 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Statement Of Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 2,660 | 2,644 | 2,018 | 1,394 | 1,381 | 1,345 | 1,282 | 1,159 | 1,145 | 923 | 724 | 714 | ||||||
| Retained Earnings Accumulated Deficit | -1,316 | -1,233 | -1,140 | -1,051 | -977 | -906 | -837 | -778 | -726 | -693 | -654 | -627 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -3 | -2 | 1 | 1 | 0 | 1 | 1 | 1 | -0 | 0 | 0 | 0 | ||||||
| Stockholders Equity | 1,341 | 1,410 | 878 | 344 | 404 | 439 | 445 | 383 | 419 | 230 | 70 | 87 | ||||||
| Liabilities And Stockholders Equity | 1,390 | 1,460 | 938 | 396 | 453 | 479 | 483 | 416 | 441 | 250 | 88 | 107 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 28 | 28 | 25 | 21 | 21 | 20 | 19 | 18 | 18 | 13 | 9 | 9 | ||||||
| Shares Outstanding | 28 | 28 | 25 | 21 | 21 | 20 | 19 | 18 | 18 | 13 | 9 | 9 | ||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPraxis Precision Medicines, Inc. (PRAX) — SEC Financial Statements & Analysis
Praxis Precision Medicines, Inc. (PRAX) is a pharmaceutical preparations company, incorporated in DE. Praxis Precision Medicines, Inc. trades on Nasdaq as: PRAX. Praxis Precision Medicines, Inc. (PRAX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Praxis Precision Medicines, Inc. carries a market cap of $9.75B, a P/E ratio of -28.76x, a P/B ratio of 7.27x, a P/S ratio of 156.08x, an enterprise value of $9.28B, and an EV/EBITDA multiple of -24.54x. On profitability, it posts an operating margin of -3927.51%, a net margin of -3658.53%, a Return on Equity (ROE) of -38.86%, a Return on Assets (ROA) of -36.80%, and a Return on Invested Capital (ROIC) of -67.94%. Per share, it reports EPS of $-11.64, diluted EPS of $-11.64, free cash flow per share of $-10.48, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 35.10% year-over-year, and EPS growth of -0.41% year-over-year. On the balance sheet, it maintains a current ratio of 15.73x, a quick ratio of 15.46x, working capital of $722.85M, a debt-to-equity ratio of 0.04x, a debt ratio of 0.04, free cash flow of $-305.38M (TTM), and net debt of $-474.76M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.75B
- P/E TTM
- -28.76x
- EPS TTM
- $-11.64
- P/B TTM
- 7.27x
- ROE TTM
- -38.86%
- ROA TTM
- -36.80%
- Debt To Equity
- 0.04x
- Free Cash Flow TTM
- $-305.38M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Praxis Precision Medicines, Inc. in?
Praxis Precision Medicines, Inc. (PRAX) operates in the Pharmaceutical Preparations industry.
What exchange does PRAX trade on?
Praxis Precision Medicines, Inc. (PRAX) trades on the Nasdaq.
Where is Praxis Precision Medicines, Inc. incorporated?
Praxis Precision Medicines, Inc. is incorporated in DE.
When was Praxis Precision Medicines, Inc. (PRAX)'s most recent SEC filing?
Praxis Precision Medicines, Inc. (PRAX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is PRAX's market cap?
Praxis Precision Medicines, Inc. (PRAX) has a market capitalization of $9.75B as of 2026-06-30.
What is PRAX's EPS (earnings per share)?
Praxis Precision Medicines, Inc. (PRAX)'s trailing twelve month EPS is $-11.64 as of 2026-06-30.
What is PRAX's ROE (return on equity)?
Praxis Precision Medicines, Inc. (PRAX)'s trailing twelve month Return on Equity (ROE) is -38.86% as of 2026-06-30.
What is PRAX's ROA (return on assets)?
Praxis Precision Medicines, Inc. (PRAX)'s trailing twelve month Return on Assets (ROA) is -36.80% as of 2026-06-30.
What is PRAX's ROIC (return on invested capital)?
Praxis Precision Medicines, Inc. (PRAX)'s trailing twelve month Return on Invested Capital (ROIC) is -67.94% as of 2026-06-30.
What is PRAX's EV/EBITDA?
Praxis Precision Medicines, Inc. (PRAX)'s trailing twelve month EV/EBITDA is -24.54x as of 2026-06-30.